Effects of beta-adrenoceptor agonists and antagonists in patients with peripheral autonomic neuropathy.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000420:Albuterol / Q000627:therapeutic use; D000686:Amyloidosis / Q000188:drug therapy; D001342:Autonomic Nervous System Diseases / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy*; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy*; D010869:Pindolol / Q000627:therapeutic use; D011187:Posture; D011433:Propranolol / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D011433:Propranolol; D010869:Pindolol; D008790:Metoprolol; D007545:Isoproterenol; D000420:Albuterol